Ennogen Healthcare Ltd, Otomize Ear Spray joins generic market
Please be aware that Otomize Ear Spray is going generic. It will now be called Dexamethasone/Neomycin Sulfate/Acetic Acid 0.1%w/w / 0.5%w/w / 2% w/w Ear Spray – The product itself remains unchanged.
Ennogen do not anticipate any supply disruption as a result of this change.
There will be a period where both branded (Otomize) and non-branded (Dexamethasone/ Neomycin sulfate / Acetic acid 0.1%w/w / 0.5%w/w / 2% w/w Ear Spray) stock is supplied, whilst branded stock is rundown.
There will be no change in supply route so please continue to order as usual.